448 related articles for article (PubMed ID: 30744686)
1. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Williams EC; Matson TE; Harris AHS
Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.
Harris AH; Bowe T; Hagedorn H; Nevedal A; Finlay AK; Gidwani R; Rosen C; Kay C; Christopher M
Addict Sci Clin Pract; 2016 Sep; 11(1):15. PubMed ID: 27633982
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
[TBL] [Abstract][Full Text] [Related]
5. Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.
Del Re AC; Gordon AJ; Lembke A; Harris AH
Addict Sci Clin Pract; 2013 Jul; 8(1):12. PubMed ID: 23835352
[TBL] [Abstract][Full Text] [Related]
6. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.
Finlay AK; Ellerbe LS; Wong JJ; Timko C; Rubinsky AD; Gupta S; Bowe TR; Burden JL; Harris AHS
J Subst Abuse Treat; 2017 Jun; 77():38-43. PubMed ID: 28476269
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
Abraham AJ; Knudsen HK; Roman PM
J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
[TBL] [Abstract][Full Text] [Related]
8. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
[TBL] [Abstract][Full Text] [Related]
9. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
[TBL] [Abstract][Full Text] [Related]
10. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
12. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration.
Taylor E; Timko C; Harris AHS; Yu M; Finlay AK
Addict Sci Clin Pract; 2019 Jan; 14(1):1. PubMed ID: 30602392
[TBL] [Abstract][Full Text] [Related]
13. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
[TBL] [Abstract][Full Text] [Related]
14. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
15. Geographic differences in receipt of addictions treatment in a national sample of patients with alcohol use disorders from the U.S. Veterans Health Administration.
Edmonds AT; Bensley KM; Hawkins EJ; Williams EC
Subst Abus; 2021; 42(4):559-568. PubMed ID: 32821028
[No Abstract] [Full Text] [Related]
16. Advances in Pharmacotherapy Development: Human Clinical Studies.
Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
[TBL] [Abstract][Full Text] [Related]
17. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
[TBL] [Abstract][Full Text] [Related]
18. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
[TBL] [Abstract][Full Text] [Related]
19. Overview of Alcohol Use Disorder.
Kranzler HR
Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
[TBL] [Abstract][Full Text] [Related]
20. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
